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Abstract
EXAMINING THE EFFECT OF RACE ON THE RELATIONSHIP BETWEEN
POSTTRAUMATIC STRESS DISORDER AND METABOLIC SYNDROME IN
WOMEN
By: Leia A. Harper, MDiv
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University
Virginia Commonwealth University, 2014
Major Director: Scott Vrana, Ph.D.
Professor of Psychology
Department of Psychology

Posttraumatic stress disorder (PTSD) is a psychiatric condition affecting approximately
8% of the adult U.S. population with rates twice as high in women than men.
Increasingly, evidence has suggested a close relationship between PTSD and increased
risk of metabolic diseases. However, the literature on PTSD and metabolic disease risk
factors has been limited by the lack of investigation of the potential influence of race on
this relation. The current study examined the possible effect of race on the relation
between PTSD and metabolic risk. Data for this study were provided from sample of that
included 50 African American women and 39 Caucasian women, 56.2% and 43.8%
respectively. Results support the importance of race in the relationship between PTSD
and metabolic disease risk factors. Future research would benefit from analysis of

cultural factors to explain how race might influence the course of metabolic disease risk
and development in women with PTSD.

Examining the Effect of Race on the Relationship Between
Posttraumatic Stress Disorder and Metabolic Syndrome in Women
Posttraumatic stress disorder (PTSD) is a psychiatric condition that can develop
after an individual is confronted with a traumatic event involving actual or threatened
death or injury. In order to receive a diagnosis of PTSD, the individual’s response must
involved intense fear, helplessness, or horror (American Psychiatric Association. Task
Force on DSM-IV. & American Psychiatric Association., 2000). The essential
characteristics of PTSD include a cluster of symptoms lasting for at least a month causing
significant distress and/or impairment. These essential features include re-experiencing,
or intrusive recollections of the traumatic event, efforts to avoid anything associated with
the event, numbing of emotions, and hyperarousal, which is often manifested by
difficulty sleeping and/or concentrating together with increased irritability (Institute of
Medicine (U.S.). Subcommittee on Posttraumatic Stress Disorder of the Committee on
Gulf War and Health: Physiologic, 2006).
The overall lifetime prevalence of PTSD is 8% in the U.S. adult population
(American Psychiatric Association. Task Force on DSM-IV. & American Psychiatric
Association., 2000). Research has shown that women suffer from PTSD more frequently
and experience PTSD symptomology more intensely than men (N. Breslau & Davis,
1992; Davidson, Hughes, Blazer, & George, 1991; Kessler, Sonnega, Bromet, Hughes, &
Nelson, 1995; Tolin & Foa, 2006). Further, studies have also shown that the rate of PTSD
is twice as high in women as in men (N.; Breslau, 2001; N. Breslau et al., 1998; Kessler
et al., 1995) with estimates of 10% in women compared to 5% in men (Kessler et al.,
1995). Women are also twice as likely to develop PTSD following a traumatic event and
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are more likely to develop chronic symptoms of PTSD (N. Breslau & Davis, 1992; N.
Breslau, Davis, Andreski, Peterson, & Schultz, 1997; Calhoun, Wiley, Dennis, &
Beckham, 2009).
Increased rates of mood, anxiety, and substance use disorders are often comorbid
with PTSD. Data from the National Comorbidity Survey indicated that 79% of women
with a history of PTSD had at least one additional psychiatric disorder and 49% report a
history of at least one major depressive episode (Kessler, Chiu, Demler, Merikangas, &
Walters, 2005). Research has also shown that women with a PTSD diagnosis are four
times more likely to develop major depressive disorder (MDD) as women who do not
have PTSD (Brady, Killeen, Brewerton, & Lucerini, 2000). MDD is one of the leading
causes of disease and disability worldwide, affecting 16.9% of the U.S. population
(Bromet et al., 2011). Like PTSD, MDD is twice as likely to be diagnosed in women as
in men, and women have a 70% greater chance of experiencing depression during their
lifetime than men (Kessler, Berglund, et al., 2005).
In addition to gendered differentials, research has also shown that symptoms of
anxiety and depression present differently across racial groups. A study using data from
the National Epidemiologic Survey on Alcohol and Related Conditions found that in a
sample of 34,653 adults the lifetime prevalence of PTSD in African Americans (8.7%)
was significantly higher than what was found in both Caucasian (7.4%), and the general
population (7.3%) (Roberts, Gilman, Breslau, Breslau, & Koenen, 2011). Contrary to
PTSD, research has indicated that the lifetime prevalence of MDD is higher in
Caucasians (17.9%) than in both African Americans (10.4%) and the general population
(16.2%) (Kessler et al., 2003). However, research has also shown that African Americans
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have higher rates of chronic episodes of depression (56.5%) compared to Caucasians
(38.6%) (Williams et al., 2007). In addition, relative to Caucasians, when African
Americans are diagnosed with MDD it usually goes untreated and is more severe and
disabling (J. Breslau, Kendler, Su, Gaxiola-Aguilar, & Kessler, 2005).
In addition to race and gender differences in risk of poor mental health outcomes,
race and gender also are related to cardiovascular disease risk. One in three female adults
in the U.S. have some form of cardiovascular disease (CVD). Mortality rates for women
are much higher in cardiac related diseases than the next five causes of death combined.
The risk for prevalence and mortality in CVD increases significantly in ethnic minority
populations, particularly African Americans. Nearly half of African American women
have some form of CVD, compared to about one-third of Caucasian women (Roger et al.,
2012).
Metabolic syndrome (MetS) is a cluster of metabolic risk factors that has long
been a representative factor in the identification of CVD risk, the development of type II
diabetes, and the increased risk of stroke. The metabolic risk factors that make up
metabolic syndrome are abdominal obesity, elevated fasting plasma glucose levels, HDL
cholesterol levels, triglyceride levels, and systolic or diastolic blood pressure levels, and a
person is identified as having metabolic syndrome if they have three or more of these risk
factors over a defined level. The management of MetS is an important component in
addressing the global epidemics of CVD and diabetes mellitus. Compared to individuals
without MetS, research has shown that individuals with MetS have a 2-fold increase in
CVD risk (Gami et al., 2007; Mottillo et al., 2010), and a 5-fold increase in diabetes risk
(Stern, Williams, Gonzalez-Villalpando, Hunt, & Haffner, 2004). Further, health care
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cost increase by 24% for each additional metabolic risk factor present, making MetS a
critical component in addressing the rising cost of healthcare (Boudreau et al., 2009).
As with cardiovascular disease, the prevalence of metabolic syndrome varies by
race and gender. Data from the National Health and Nutrition Examination Survey
(2007-2008) revealed that, in men, metabolic syndrome was more prevalent in Caucasian
men (37.2%) than in African American men (25.3%), while data from women indicated
that metabolic syndrome was more prevalent in African American women (38.5%),
compared to Caucasian women (31.5%) (Ervin, 2009). Also, the prevalence of MetS is
53% higher among African American women than among African American men (Roger
et al., 2012), further demonstrating the disparate burden of MetS among African
American women.
Increasingly,

evidence

has

suggested

a

close

relationship

between

psychopathology and physical health (Eaton, Armenian, Gallo, Pratt, & Ford, 1996;
Katon & Ciechanowski, 2002; Schnurr & Green, 2004). Research has shown that PTSD
has been linked to several negative health outcomes related to metabolic abnormalities
such as higher rates of obesity (David, Woodward, Esquenazi, & Mellman, 2004; Dedert,
Becker, et al., 2010), higher lipid levels (Karlovic, Buljan, Martinac, & Marcinko, 2004;
Karlovic, Martinac, Buljan, & Zoricic, 2004), as well as increased risk of hypertension
(Kibler, Joshi, & Ma, 2009), myocardial infarction (Kubzansky, Koenen, Spiro, Vokonas,
& Sparrow, 2007), and cardiovascular mortality (Boscarino, 2008; Dedert, Calhoun,
Watkins, Sherwood, & Beckham, 2010). Additionally, there may be gender and race
differences in the association between physical and mental health. For example, the
Third National Health and Nutrition Examination Survey, which included 3,186 men and
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3,003 women, found that the prevalence of MetS was elevated in women with a history
of depression, while men with a history of depression were not significantly more likely
to have MetS (Kinder, Carnethon, Palaniappan, King, & Fortmann, 2004).
The literature has cited a number of mechanisms underlying the health disparities
found in both gender and race, citing family history, socioeconomic status, dietary habits,
sedentary lifestyle, and substance misuse (Roger et al., 2012). Yet, little research has
considered the implications of psychiatric conditions in relation to adverse health in
women or in minority populations. Considering the disparities found in both health and
trauma exposure, African American women who experience symptomology related to
PTSD and comorbid MDD are of particular interest in the current study. African
American women are at the intersection of heightened prevalence across categories of
race and gender, and there is extensive literature linking these psychiatric conditions to
multiple adverse health outcomes.
As a possible explanation of the increased prevalence of risk factors for
cardiovascular morbidity and mortality in African American women, this study
hypothesizes that the higher incidence and prevalence of metabolic risk factors are due, at
least in part, to higher rates of trauma exposure and the subsequent development of PTSD
and MDD. Thus, the current project aims to investigate the association of psychiatric
diagnoses with metabolic risk factors and metabolic syndrome among a sample of
Caucasian and African American women.

5

Review of the Literature
There is a growing body of literature documenting the relationship between PTSD
and metabolic risk factors. Research has demonstrated that various psychosocial domains,
including socioeconomic status, race, gender and occupation, can often moderate these
relationships. Yet research examining the compounded effects of these demographic
domains is relatively scarce. In order to further investigate the implications of racial
status on the relationship between PTSD and MetS in women, the literature will be
surveyed and reported with particular attention given to research focusing on racial
and/or gender differences.
Posttraumatic stress disorder.
Gender effects in posttraumatic stress disorder. In 1980, the DSM-III was
published, and with it, the first official definition of PTSD. The categorization of trauma
symptoms into the DSM had been prompted by the high prevalence of Vietnam veterans,
primarily male, seeking treatment for distinct post-trauma symptoms (Figley, 1985).
Interestingly, subsequent research has suggested not only that PTSD is more prevalent
among women than men (N. Breslau & Davis, 1992; N. Breslau et al., 1998), but that
women are at greater risk than men of developing PTSD following trauma exposure (N.
Breslau, Davis, Andreski, et al., 1997; N. Breslau, Davis, Peterson, & Schultz, 1997).
Tolin & Foa, 2006 conducted a meta-analysis reviewing sex-specific risk of
potentially traumatic events and PTSD. This review included published literature dated
from the introduction of PTSD in 1980 through July 2005. By identifying articles that
investigated the prevalence of potentially traumatic events and PTSD among male and
female participants, Tolin & Foa sought to answer what they identified as four key
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questions. 1) Are women and girls more likely than men and boys to meet diagnostic
criteria for PTSD? 2) Are women and girls more likely than men and boys to experience
a traumatic event? 3) Do male and female participants differ in terms of the type of
traumatic experience? 4) Do sex differences in PTSD remain when controlling for the
type of traumatic event? The literature search yielded 290 articles with data to address
these questions. They found that 1) women and girls were more likely than men and
boys to meet criteria for PTSD following a traumatic event, 2) adult male participants
were significantly more likely to report a traumatic experience than were adult females,
and 3) the trend of males reporting more traumatic events appears to only be true for
certain events (i.e. accidents, nonsexual assault, witnessing an assault, combat, natural
disasters, and serious illness or injury). The fourth and final of the tested hypotheses saw
mixed results. Findings suggest that though women have higher levels of PTSD
prevalence and severity, gender differences in traumatic event frequency was moderated
in part by the methods employed during the study. When the occurrence of the traumatic
event was assessed over a discrete time period (e.g., the past year) rather than the
individual’s lifetime, there were no significant gender differences. The researchers
deduced that this lack of consistency could have been due to the limited number of
traumatic events that may have occurred during that period.
Race effects in posttraumatic stress disorder. Research examining race
differences in trauma exposure and the development of PTSD is extremely limited. The
National Comorbidity Survey Replication (NCS-R) is a nationally representative survey
conducted using the World Mental Health version of the Composite International
Diagnostic Interview. Using data from this survey Breslau et al. (2006) examined the
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variation in race of lifetime risk and prevalence of DSM-IV disorders. Findings from this
study indicated a 7.1% lifetime prevalence of PTSD in African Americans, compared to
6.8% in Caucasian, a small and not statistically significant difference between the two (J.
Breslau et al., 2006).
In 2009 Himle and colleagues combined data from the NCS-R and the National
Survey of American Life (NSAL) in a study estimating the prevalence, ages of onset,
severity, and associated disability of anxiety disorders among African Americans,
Caribbean Blacks, and Caucasians. The researchers found that Caucasians had elevated
odds of all 12-month anxiety disorders except PTSD, and that the lifetime prevalence of
PTSD was greater in African Americans (9.1%) and Black Caribbeans (8.4%) than in
Caucasians (6.8%) (Himle, Baser, Taylor, Campbell, & Jackson, 2009).
Another study used data from the 2004-2005 wave of the National Epidemiologic
Survey on Alcohol and Related Conditions (NESARC) to identify the sources of
race/ethnic differences in PTSD. The NESARC uses a multi-stage sampling design
yielding a representative sample of the civilian, non-institutionalized U.S. population
over the age of 18 years. Using a sample of 34,653 adults, the researchers found that the
lifetime prevalence of PTSD in African Americans (8.7%) was significantly higher than
what was found in both Caucasian (7.4%), and the general population (7.3%) (Roberts et
al., 2011).
Metabolic syndrome. There is growing evidence linking trauma exposure and
diminished physical health, particularly cardiovascular related diseases. MetS is a cluster
of metabolic risk factors that has been shown to be a significant predictor of CVD and
diabetes. Though many different definitions have been proposed for MetS, in 2009 the
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International Diabetes Federation, the National Heart, Lung, and Blood Institute, the
American

Heart

Association,

the

World

Heart

Federation,

the

International

Atherosclerosis Society and the International Association for the Study of Obesity
initiated a task force in order to standardize a definition (Alberti et al., 2009). As such, a
diagnosis of MetS is given when three or more of the following five risk factors are
present:
•

Fasting plasma glucose greater than or equal to 100 mg/dL or undergoing drug
treatment for elevated glucose.

•

HDL cholesterol less than 40 mg/dL in men or less than 50 mg/dL in women
or undergoing drug treatment for reduced HDL cholesterol.

•

Triglycerides greater than or equal to 150 mg/dL or undergoing drug
treatment for elevated triglycerides.

•

Abdominal obesity, or a waist circumference greater than or equal to 102 cm
for men or greater than or equal to 88 cm for women (in the United States).

•

Blood pressure greater than or equal to 130 mm Hg systolic or greater than or
equal to 85 mm Hg diastolic or undergoing drug treatment for hypertension or
antihypertensive drug treatment in a patient with a history of hypertension
(Roger et al., 2012).

Thus, throughout this thesis, I will use the term metabolic risk factor when referring to
one or more of the five risk factors listed above, and metabolic syndrome when I am
referring to the presence of three or more of the five metabolic risk factors. Additionally,
due to the varying methods used in assessing glucose metabolism, it is important to note
differences in these terms as well. Insulin is a hormone produced in the pancreas that
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helps regulate the way the body metabolizes food. As the digestive tract breaks down
carbohydrates into glucose, the pancreas releases insulin into the blood the bloodstream.
With the help of insulin, cells throughout the body absorb glucose and use it for energy.
Insulin resistance is a condition in which the body produces insulin but does not use it
effectively. Over time, insulin resistance can lead to diabetes as the pancreas fails to keep
up with the body’s increased demand for insulin. The lack of sufficient levels of insulin
leads to excess glucose in the bloodstream, which, in turn, results in diabetes and/or other
adverse health conditions. Fasting glucose testing, or glucose tolerance testing are
methods used to assess how well the body metabolizes glucose. Fasting insulin tests
assess the amount of insulin in the bloodstream. High levels of insulin are indicative of
insulin resistance; in which case the pancreas is overproducing in order to maintain
healthy blood glucose levels. These methods will be further discussed later within this
paper.
Gender and race effects in metabolic risk factors. As of 2008, approximately
35% of women over the age of 20 years old have some form of CVD with the risk for
prevalence and mortality in CVD increasing significantly in ethnic minority populations
(Roger et al., 2012). In 2008, the death rates from CVD were 200.5 per 100,000 for nonHispanic white females and 277.4 per 100,000 for non-Hispanic black females. Since
1984, the number of CVD deaths for females have exceeded those of males, with females
representing 51.7% of deaths from CVD (Roger et al., 2012). Yet, surprisingly, women
are vastly underrepresented in research, comprising only 24% of most heart-related
studies (Johnson, Karvonen, Phelps, Nader, & Sanborn, 2003), with even fewer exploring
the implications of race.
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African Americans, and particularly African American women, bear a
disproportionate physical burden from metabolic related conditions. As a group, African
Americans have diabetes at a rate that is more than three times that of Caucasians and
have a 40% higher prevalence rate of heart disease (Mental Health: Culture, Race, and
Ethnicity: A Supplement to Mental Health: A Report of the Surgeon General, 2001). The
prevalence of hypertension in African Americans is 41.4% compared to 28.1% in
Caucasians, and is highest (44.0%) among African American women (Roger et al., 2012).
Nearly half of African American women have some form of CVD, compared to about
one-third of Caucasian women (Roger et al., 2012), and while the prevalence of CVD is
higher in white men (37.4%) than in white women (33.8%), African American women
have a higher prevalence of CVD (47.3%) than that of African American men (44.8%)
(Roger et al., 2012). Additionally, the prevalence of diagnosed diabetes is 1.4 times as
frequent in African Americans as in Caucasians with the risk of diabetes being 77%
higher among African Americans. African American women are especially affected. The
age-adjusted incidence of diabetes diagnosis is 15% for African American women,
compared to 10.9% for African men and 7.0% and 6.9% for Caucasian men and women,
respectively (Lipton, Liao, Cao, Cooper, & McGee, 1993).
The identification of metabolic syndrome represents either the presence of or an
increased long-term risk for developing chronic cardiovascular and metabolic conditions.
Just as there are gender and racial differentials in the prevalence of CVD, research has
found similar disparities in the prevalence of MetS. The age-adjusted prevalence of MetS
was 35.1% for men and 32.6% for women, 37.2% for Caucasians and 25.3% for African
Americans. Among women, prevalence rates for MetS are 31.5% for Caucasian women
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and 38.8% for African American women. What is interesting about the statistics for MetS
are the ways in which the numbers are similar to those of CVD. Though Caucasians have
an overall higher prevalence of MetS, Caucasian women have a lower rate than those of
Caucasian men, while African American women have a higher prevalence than those of
African American men; approximately 53% higher (Roger et al., 2012).
Metabolic syndrome and posttraumatic stress disorder. The initial evidence
of the relationship between traumatic stress and MetS was drawn from research on CVD
following traumatic stress. A longitudinal study investigated the relationship between
exposures to wartime events, CVD and all-cause mortality in Lebanon following a 16year civil war. The authors of this study reported a total of 416 deaths in a cohort of 1,567
men and women during the 10-year follow-up, with CVD accounting for 60% of the total
(237 men and 179 women). Yet, mortalities from physical injuries sustained as a result of
war were less than 2% (Sibai, Fletcher, & Armenian, 2001). Note that CVD related
mortalities dwarfs those due to physical injuries sustained during the war. Kang, Bullman
& Taylor investigated the association between PTSD and CVD in World War II prisoners
of war (POWs). In this study, the researchers found that compared to non-POWs and
POWs without PTSD, POWs with PTSD had an increased likelihood of hypertension and
chronic heart disorders (Kang, Bullman, & Taylor, 2006).
Heppner et. al, 2009 analyzed clinical data from 253 male and female veterans in
order to examine the association between PTSD, PTSD symptom severity and MetS.
PTSD diagnosis and symptom severity was measured using the Clinician Administered
PTSD Scale (CAPS). MDD and substance use disorders (SUD) were assessed using a
structured diagnostic interview. The researchers in this study used clinical cut-offs
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defined by the World Health Organization and the National Cholesterol Education
Program for MetS status. The overall prevalence of MetS in this sample was 39.9%.
Among individuals with comorbid PTSD and MDD, 46.2% met criteria for MetS
compared to 34.3% in those with PTSD only and 28.8% with MDD only. Heppner and
colleagues also found that the CAPS total score was a significant predictor of MetS such
that an individual’s risk for MetS increased one percentage point for each point obtained
on the CAPS. Results from this study indicate that PTSD is a significant predictor of
MetS, and, that as PTSD symptom severity increases, the likelihood of meeting criteria
for MetS also increases (Heppner et al., 2009).
Similarly, Violanti et al. (2006) conducted a study in which a sample of male and
female police officers were administered the Impact of Events Scale, which is a scale that
measures PTSD symptomology. The investigators found that the officers with more
severe PTSD symptoms had a significantly higher prevalence of MetS (50%) than those
with subclinical symptoms (15.1%) (Violanti et al., 2006). A study using a sample of
Croatian combat veterans found that the prevalence of metabolic syndrome was related to
the severity of PTSD. Veterans with severe symptomology had a 66.7% prevalence rate
of MetS compared to only 23.3% in veterans with subclinical symptomology (Babic et
al., 2007). Jakovljevi et al. examined the prevalence of MetS in a sample of Croatian war
veterans with PTSD. The investigators found that 31.9% of the veterans with PTSD met
criteria for MetS, compared to only 8.9% of the age matched controls (Jakovljevic, Saric,
Nad, Topic, & Vuksan-Cusa, 2006).
One study examined whether PTSD was a risk factor for the development of
MetS among an impoverished urban population (Weiss et al., 2011). The researchers

13

recruited 245 low-socioeconomic-status participants in which 18.8% met criteria for
current PTSD and 33.2% met criteria for MetS. The researchers found that a current
diagnosis of PTSD was significantly associated with the presence of MetS. Also, after
controlling for demographics, smoking history, antipsychotic use, depression and
exercise, current PTSD remained the only significant predictor of MetS (Weiss et al.,
2011).
Another important construct in considering the relationship between PTSD and
MetS is hostility, a construct known to be symptomatic of PTSD. Vitaliano and
colleagues examined the relationship of psychosocial factors, including hostility, with
fasting insulin and glucose levels. Using the State-Trait Anger Scale to assess hostility,
the authors of this study found that participants with high anger/hostility scores had
significantly higher blood glucose levels than those who were low on these factors
Additionally, hostility was associated with insulin and glucose levels even after
controlling for obesity, cholesterol, and cardiovascular disease (Vitaliano, Scanlan,
Krenz, & Fujimoto, 1996).
In 2000, Niaura and colleagues examined the associations between hostility and
metabolic disease risk factors in 1081 men. Hostility was measured using the CookMedley Hostility Scale (Ho), which was derived from the Minnesota Multiphasic
Personality Inventory. The researchers found that the total Ho score was positively
associated waist to hip ratio, BMI, fasting insulin levels, blood pressure and triglyceride
levels (Niaura et al., 2000).
Another study examined the relationship between cynical hostility and the
incidence of diabetes and MetS in a sample of women. Using the cynicism subscale of
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the Cook-Medley Hostility Questionnaire to assess cynical hostility, the researchers
found that women with high cynical hostility scores had higher BMI. Also, the incident
of diabetes was 36% higher among women with high cynical hostility scores. Another
interesting finding to note in this study was the association of hostility and race. Cynical
hostility scores were associated with race such that African American women had higher
levels compared to Caucasian women (Wylie-Rosett et al., 2010).
Women, race, metabolic disease risk, and psychopathology. The association
of poorer physical health with psychiatric symptomology is greater in African Americans
than in Caucasians, particularly disorders related to glucose metabolism. Cooper &
Waldstein (2004) conducted a study to examine if hostility influences racial disparities in
cardiovascular disease. The sample included 66 adults aged 18 -26 years old and
examined the following metabolic risk factors: systolic and diastolic blood pressure,
cardiac index (i.e. cardiac output adjusted for body size), total peripheral resistance (i.e.
the overall resistance to blood flow in the blood vessels), insulin levels, triglyceride
levels and percent body fat. The researchers included total peripheral resistance and
cardiac index because these are hallmarks of hypertension (Lund-Johansen, 1994). The
researchers found that hostility scores were higher among African Americans than
Caucasians, and that while African Americans had significantly higher HDL cholesterol,
Caucasians had higher triglyceride levels. Hostility was positively associated with
systolic and diastolic blood pressure, insulin levels and triglyceride levels among African
Americans. Conversely, hostility was negatively associated with total peripheral
resistance and percent body fat among Caucasian participants. Overall, the results
suggested that hostility potentiated metabolic risk in African Americans and diminished
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risk among Caucasians (Cooper & Waldstein, 2004).
Georgiades and colleagues conducted a study to determine whether the
relationship of hostility to fasting glucose was moderated by sex and race. A total of 565
men and women were assessed using the Cook-Medley hostility scale. Results showed a
moderating effect of race and sex on the association of hostility to fasting glucose but not
for insulin. There was a positive association between hostility and fasting glucose in
African American women only. This association remained significant after controlling
for age and body mass index (Georgiades et al., 2009).
In 2004, Everson-Rose et al. published findings from a study examining the
relationship between depressive symptoms, insulin resistance and risk of diabetes in a
multiracial community sample of middle-aged women. Participants were from the Study
of Women’s Health Across the Nation (SWAN), an ongoing longitudinal study of
menopausal transition. Depression was assessed using the 20-item Center for
Epidemiological Studies Depression Scale (CES-D); insulin resistance was calculated by
using a computer algorithm known as the revised homeostasis model assessment of
insulin resistance (HOMA-IR) model via blood draw following a 12-hour fast; and the
incidence of diabetes was obtained via self-report and fasting glucose levels. The
researchers found that diabetes was 66% more likely to develop in depressed women than
in without depression. Depressed women, also, had significantly greater fasting glucose
levels than those without depression, even after adjusting for age, race, education and
medication use. Additionally, Everson-Rose and colleagues found that while depression
was associated with higher fasting glucose level and incident diabetes, African-American
women with depression experienced an increased risk of diabetes independent of central
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adiposity and obesity. These findings suggest that there may be additional mechanisms
that contribute to the excess risk of diabetes experienced by African-American women.
The current project hypothesizes that trauma exposure and subsequent psychiatric
symptomology may account, at least in part, for these differences.
The association of poorer physical health with psychiatric symptomology is
greater in women than in men. In 2006, Edward Suarez conducted a study examining sex
differences in the relation of depressive symptomatology, hostility and anger expression
to glucose metabolism. Suarez used the Beck Depression Inventory to measure
depressive symptoms, the Cook Medley Hostility Scale to assess hostility, and the
Spielberger Anger Expression scale to assess anger. Suarez found that the severity of
depressive symptoms, higher levels of hostility, and a propensity to express anger were
all significantly associated with higher levels of fasting insulin and glucose levels in
women, but not in men. Also, these associations remained significant independent of
BMI, age, triglyceride levels, alcohol consumptions and educational status (Suarez,
2006).
Another study to examine different relationships between psychopathology and
metabolic risk explored the effect of race on metabolic disease risk factors in women with
and without PTSD (Dedert, Harper, Calhoun, Dennis, & Beckham, 2012). The current
project seeks to replicate and extend this research, and as such, will provide a more
detailed analysis of this study. Data for were provided by a sample of 134 women. The
sample had a mean age of 40.4 (SD = 12.9). In that study, the researchers testEd for
demographic differences by PTSD, MDD, substance use disorder (SUD), and race
(African American vs. Caucasian) using general linear models for continuous variables
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and Chi-square tests for categorical variables.
The study found that participants with current MDD had a higher mean age and
lower SES, but no between-group difference in race. Participants with a lifetime
substance use disorder (SUD) had a lower SES, but no significant differences in age or
race. A greater number of Axis I disorders was generally associated with lower SES, but
there was no significant relationship of Axis I disorders with age or race. Individuals with
PTSD had higher BMI, larger abdominal obesity, and higher systolic blood pressure.
Examination of associations between race and metabolic disease risk factors revealed that
African American participants had larger abdominal obesity, and lower triglycerides.
Results from general linear models examining associations of race and psychiatric
disorders revealed a race by PTSD interaction in BMI, such that Caucasians without
PTSD had a lower BMI than Caucasians with PTSD. Caucasians without PTSD also had
a lower BMI than racial minorities regardless of PTSD diagnosis. Similarly, there was an
interaction of PTSD and race on obesity, such that Caucasians without PTSD had lower
rates of obesity and lower abdominal obesity than each of the other groups. Also, there
was an interaction for triglycerides, such that Caucasians with PTSD had higher
triglycerides than each of the other groups.
Models testing the association of MDD and race with disease risk factors revealed
that MDD was associated with elevations in BMI, obesity rate, waist-hip ratio, LDL
level, and triglyceride level. In contrast to models with PTSD, the models with MDD
resulted in no interactions of MDD with race. A history of SUD was associated with
higher systolic blood pressure, but no other health risk measures. There were no
interactions of SUD history with race in models of metabolic risk measures. The number
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of total axis I disorders was associated with an increased rate of obesity, larger waist-hip
ratio, higher LDL levels, and higher triglyceride levels.
Findings from this study indicate that race plays a significant role in the
association of PTSD with metabolic risk factors, particularly as only systolic blood
pressure did not also have a significant interaction between PTSD and race where all
other metabolic factors did. However, contrary to what was expected, PTSD did not have
as great of an effect on metabolic risk factors in African American women as what was
found in Caucasian women. This was found to be true in abdominal obesity, BMI,
obesity rates, and triglycerides. There was no significant increase in rates of obesity,
triglyceride levels, waist to hip ratio, or systolic blood pressure in African American
women with PTSD.
Statement of the problem. While evidence has shown that gender and race are
critical aspects in metabolic disease risk factors as well as PTSD symptomology, the
effect of these variables has received little empirical attention in assessing the
relationship between PTSD and MetS. The current project seeks to replicate and extend a
previous study that examined metabolic risk in women with and without PTSD (Dedert et
al., 2012). Dedert et al., found that while PTSD did not have a significant effect on
certain metabolic risk factors in African Americans, it was associated with a notable
worsening of metabolic risk in Caucasians. While these patterns were noted in abdominal
obesity, BMI, obesity rates, and triglycerides, a limitation of this study was the absence
of fasting glucose data. This absence in the Dedert and colleagues study is of particular
interest because of previous data indicating that African Americans have a strong
relationship between insulin resistance and metabolic risk (Gaillard, Schuster, & Osei,
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2009, 2010; Gu, Cowie, & Harris, 1998; Meis, Schuster, Gaillard, & Osei, 2006; Zeno et
al., 2010). As such, fasting glucose and insulin resistance would be an important
component to evaluate and include when assessing MetS in African Americans. Also,
African American women tend to have higher fasting glucose levels, and higher rates of
and mortality from diabetes (Roger et al., 2012). Additionally, studies have shown a
significant positive association between hostility, a personality construct that commonly
co-occurs with PTSD (Beckham, Calhoun, Glenn, & Barefoot, 2002; Beckham, Vrana, et
al., 2002), and fasting glucose among African American women (Georgiades et al., 2009;
Surwit et al., 2009; Surwit et al., 2002). This relationship is important to note as research
has also shown that anger and hostility are common symptoms experienced by
individuals following trauma exposure.
The current project will use data from a study whose goal was to evaluate the
relationships between hostility, PTSD and biomarkers of CVD and diabetes in a younger
population. Participants were between the ages of 19 and 39. Using this data set, the
current project seeks to examine the effect of race on MetS in women with and without
PTSD. Given that the current project will replicate the work of Dedert et al. (2012), it is
hypothesized the current project will also replicate the findings from that study as well.
Hypothesis 1. Compared to Caucasian women, African American women will
have larger values on all five metabolic risk factors, and will be more likely to meet
criteria for metabolic syndrome.
Hypothesis 2. Compared to Caucasian women, African American women will
display higher rates of PTSD.
Hypothesis 3. PTSD will be associated with larger values on all five metabolic
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risk factors and increased likelihood of MetS.
Hypothesis 4. This hypothesis examines whether the relationship between
psychiatric symptoms and metabolic risk factors is different for African American and
Caucasian women. It is predicted that, consistent with previous data (Dedert et al., 2012),
Caucasian women will show a stronger association between PTSD symptoms and
triglycerides and waist circumference than will African American women. On the other
hand African American women will show a stronger association between PTSD and
insulin resistance than will Caucasian women. Based on the results of Dedert et al.
(2012), no racial differences are expected in the association between PTSD and the other
two metabolic risk factors (HDL cholesterol and blood pressure).
Method
Participants
Data for this study is provided from an investigation of hostility, PTSD, biomarkers of
CVD and type II diabetes in a trauma-exposed sample of men and women between the
ages of 19 and 39. There were a total of 206 study participants, with women representing
47.1% (N = 97). The sample consisted of 50 African American women and 39 Caucasian
women, 56.2% and 43.8% respectively. The average age was 29.91 (SD = 5.67). All
participants endorsed having experienced at least one traumatic event and 16% reported
veteran status. Additional participant demographics appear in Table 1.
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Table 1.
Means and standard deviations for independent variables
PTSD

No PTSD

African American

Caucasian

African American

Caucasian

N

27

12

23

27

Age

33.00 (4.32)

30.92 (5.49)

27.09 (6.27)

28.78 (5.05)

Education

12.19 (2.60)

13.42 (1.68)

13.76 (2.91)

15.81 (2.35)

%Employed

61.54

58.33

31.82

70.37

%Married

18.52

25.00

.45

29.63

Hollings

52.37 (13.99)

52.18 (15.53)

52.96 (13.03)

45.63 (14.93)

Cook-

15.99 (5.44)

13.42 (5.07)

11.12 (5.44)

7.22 (3.76)

DTS

70.89 (31.69)

80.50 (28.70)

23.22 (26.95)

10.78 (19.92)

BDI

19.09 (11.64)

21.73 (10.37)

7.57 (7.61)

3.88 (4.50)

Medley

Note. Values enclosed in parentheses indicate standard deviations
Recruitment. Participants were recruited from among outpatients at the Durham
Veterans Affairs Medical Center and Duke University Primary Health Care and PTSD
Clinics, and also from the community. Participants were made aware of the study through
their health care providers or through IRB approved flyers and brochures advertising a
study on stress and health posted in the medical centers. Upon contacting the lab in order
to learn more about the study protocol, subjects were asked screening questions regarding
age, medical history (specifically, HIV positive status, AIDS, diabetes, heart disease,
cancer, epilepsy, kidney disease, pregnancy, and hypertension) and psychiatric history
(specifically, history of organic mental disorder, schizophrenia, current manic syndrome,
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and current substance abuse/dependence). Individuals who met DSM-IV criteria for
organic mental disorder, schizophrenia, bipolar I mixed state or bipolar II; or current
substance abuse/dependence were excluded. Since depression is independently associated
with CVD, individuals with co-morbid lifetime or current major depressive disorder
(along with PTSD) were included as one of the group comparisons so the effect of this
co-morbidity in the presence of PTSD can be specifically examined. Those who met
criteria for lifetime substance abuse/dependence were also included. Individuals that were
pregnant and those with AIDS or who reported a positive HIV status, or who had an
uncontrolled medical conditions (e.g., kidney or liver failure), were not eligible. The
medical records of veterans enrolled at the Durham VA Medical Center were reviewed to
determine eligibility.
Procedure
Participants came in to the lab for two sessions of questionnaires and diagnostic
assessments. Study personnel collected data on racial/ethnicity, income, years of
education, age, and job status. Waist circumference was measured in centimeters. Waist
circumference was measured once for each participant, so no reliability data were
calculated for these measurements. Study participants were compensated a total of $150
for two sessions of questionnaires and diagnostic assessment.
Fasting lipids, insulin and glucose levels were determined from blood specimens.
Prior to blood draws for lipid assessment, all participants reported fasting for 12 hours.
Lipid assessment consisted of determination of high-density lipoprotein (HDL), low
density lipoprotein (LDL), and plasma triglycerides. Insulin resistance and fasting
glucose data were collected using the HOMA-IR, a commonly used surrogate for insulin
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resistance (Bonora et al., 2000). HOMA-IR is calculated as a product of the fasting
glucose (mg/dL) with lower values indicating a higher degree of insulin sensitivity.
Blood pressure was measured while participants were seated, according to AHA
guidelines, using a Datascope Accutorr Plus blood pressure monitor.
Participants were identified as meeting criteria for MetS by having three or more
of the following five risk factors:
•

Fasting plasma glucose greater than or equal to 100 mg/dL or undergoing drug
treatment for elevated glucose.

•

HDL cholesterol less than 40 mg/dL in men or less than 50 mg/dL in women
or undergoing drug treatment for reduced HDL cholesterol.

•

Triglycerides greater than or equal to 150 mg/dL or undergoing drug
treatment for elevated triglycerides.

•

Abdominal obesity, or a waist circumference greater than or equal to 102 cm
for men or greater than or equal to 88 cm for women (in the United States).

•

Blood pressure greater than or equal to 130 mm Hg systolic or greater than or
equal to 85 mm Hg diastolic or undergoing drug treatment for hypertension or
antihypertensive drug treatment in a patient with a history of hypertension.

The Clinician Administered PTSD Scale (CAPS) was administered to determine
PTSD diagnostic status (Blake et al., 1995). The CAPS is a 30-item structured interview
that corresponds to the DSM-IV criteria for PTSD and is considered the gold standard in
PTSD assessment. Symptoms are counted as present if it has a frequency of 1 or more
(scale 0 = "none of the time" to 4 = "most or all of the time") and an intensity of 2 or
more (scale 0 = "none" to 4 = "extreme"). A PTSD diagnosis is made if there is at least 1
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"B" symptom (re-experiencing), 3 "C" symptoms (avoidance), and 2 "D" symptoms
(hyperarousal) as well as meeting the other diagnostic criteria such symptom duration and
functional impairment (Blake et al., 1995; Weathers, Keane, & Davidson, 2001;
Weathers, Ruscio, & Keane, 1999) Current diagnoses are determined using a one-month
time frame.
Materials
The Structured Clinical Interview for DSM-IV (First, Spitzer, Gibbon, &
Williams, 1997) was used to diagnose other possible Axis I disorders, including
substance use disorders and MDD. To assure inter-rater reliability, study personnel
independently coded the same five charts. Kappa scores were calculated. In the case that
kappa was less than .70, the study raters coded five more medical records and the lead
investigator, Dr. Jean Beckham, reassessed reliability. Once kappa was greater than or
equal to .70, on-going inter-rater reliability throughout the record extraction was assured
by choosing one chart at random every four months for the research assistants to code.
The Davidson Trauma Scale (DTS) was used to measure PTSD symptom
severity. The DTS is a 17-item self-report measure that assesses the DSM-IV symptoms
of PTSD. Items are rated on 5-point frequency (0 = "not at all" to 4 = "every day") and
severity scales (0 = "not at all distressing" to 4 = "extremely distressing"). Participants
were asked to identify the trauma that is most disturbing to them and to rate, in the past
week, how much trouble they have had with each symptom. The DTS yields a frequency
score (ranging from 0 to 68), severity score (ranging from 0 to 68), and total score
(ranging from 0 to 136). It can be used to make a preliminary determination about
whether the symptoms meet DSM criteria for PTSD. Scores can also be calculated for
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each of the 3 PTSD symptom clusters (re-experiencing, avoidance, and hyperarousal)
(Davidson et al., 1997). For the purposes of this study, DTS severity scores will be used
to measure symptom severity. The DTS has demonstrated high test-retest and split-half
reliability, excellent internal consistency, concurrent validity, and discriminant validity
(Davidson et al., 1997). The DTS has demonstrated excellent reliability and validity in
clinical and research settings (Weathers, Keane, & Davidson, 2001; Weathers, Ruscio, &
Keane, 1999; Zanarini et al., 2000).
The Beck Depression Inventory-II (BDI-II) was used to measure depression
symptom severity. The BDI-II is a 21-item scale designed to measure severity of
depressive symptoms over a two-week period, and has demonstrated excellent test-retest
reliability, high internal consistency and high convergent validity (Beck, Guth, Steer, &
Ball, 1997; Beck, Steer, Ball, & Ranieri, 1996; Osman, Kopper, Barrios, Osman, &
Wade, 1997).
Given the high co-morbidity of PTSD and depression (Breslau, Davis, Peterson,
& Schultz, 1997; Kessler, Chiu, Demler, Merikangas, & Walters, 2005), a latent variable
was created in order to adequately capture trauma-related psychiatric symptomology.
This latent variable, which will be referred to as PTSD symptoms, was created using the
BDI to capture associated depressive symptoms and the DTS for trauma-related
symptoms.
Participants listed their current medications and provided demographic
information, including socioeconomic status based on the Hollingshead Index
(Hollingshead & Redlich, 1958). The Hollingshead Index of Socioeconomic Status is a
survey designed to measure social status of an individual based on four domains: marital
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status, retired/employed status, educational attainment, and occupational prestige.
Education is rated on a 7-point scale in which 7=graduate/professional training, 6=
standard college or university graduation, 5=partial college, at least one year of
specialized training, 4= high school graduate, 3=partial high school, 10th or 11th grade,
2= junior high school, including 9th grade, 1= less than 7th grade, 0=not applicable or
unknown. Occupational is then rated on a 9-point scale where 9=higher executive,
proprietor of large businesses, major professional, 8=administrators, lesser professionals,
proprietor of medium-sized business, 7=smaller business owners, farm owners,
managers, minor professionals, 6=technicians, semi-professionals, small business owners
(business valued at $50,000-70,000), 5=clerical and sales workers, small farm and
business owners (business valued at $25,000-50,000), 4=smaller business owners
(<$25,000), skilled manual laborers, craftsmen, tenant farmers, 3=machine operators and
semi-skilled workers, 2=unskilled workers, 1=farm laborers, menial service workers,
students, housewives, (dependent on welfare, no regular occupation), 0=not applicable or
unknown. An SES score is then calculated using the following formula: (Occupation
score x 7) + (Education score x 4) (Hollingshead & Redlich, 1958). When SES is used as
a covariate in the analysis of psychiatric variables unique differences are difficult to
detect due to the significant correlation between SES and psychiatric diagnosis (Miller &
Chapman, 2001). For this reason, SES will only be examined as a possible mediator in
the analysis of the data.
The 27-item form of the Cook-Medley Hostility Scale was used to assess
hostility. There are three subscales in this instrument including cynicism, hostile affect,
and aggressive responding. The Cook-Medley scale has shown high test-test reliability
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and a number of studies have supported its construct validity as a measure of hostility
(Barefoot, Dodge, Peterson, Dahlstrom, & Williams, 1989).
Data Analysis
In order to evaluate the association of PTSD with metabolic risk factors, the
sample was split into two groups: 1) participants with PTSD, and 2) participants without
PTSD, according to diagnostic scores from the CAPS. Because analysis of a PTSD group
with psychiatric comorbidities removed would not be representative of PTSD, all
participants with a diagnosis of PTSD were included in the analysis (Dedert et al., 2012).
Data was analyzed using SPSS.

Power analysis illustrated that with three

predictors (psychiatric diagnosis, psychiatric symptoms, and race) in the model, an n = 89
participants were sufficient to detect a small effect at .80 (80%). Prior to analysis,
psychiatric symptoms and diagnosis, race, and all metabolic variables were examined
through various SPSS programs for accuracy of data entry, missing values, and fit
between their distributions and the assumptions of multivariate analysis. The variables
were examined separately for the 89 participants. There was one missing value for HDL
cholesterol and two missing data points for waist circumference. The triplicated measures
for blood pressure were missing seven values total (one missing data point for first draw,
and three each for the second and third draws). Missing variables were calculated using
an expectation maximization (EM) algorithm in SPSS. There were two univariate outliers
that made the fasting glucose variable severely skewed (3.436) and kurtotic (20.581). A
square root transformation was used on this variable in order to improve the normality,
linearity, and homoscedasticity of the residuals.
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Results
Hypothesis 1
The first hypothesis was to evaluate racial differences in metabolic risk factors
and the likelihood of meeting criteria for MetS. A multivariate analysis of variance
(MANOVA) was performed on six dependent variables: fasting glucose, triglycerides,
diastolic and systolic blood pressure, waist circumference and HDL cholesterol. Race
was the entered as the independent variable. Means for each of these variables by race
can be found in Table 2.
Table 2.
Means and standard deviations for depend variables by race.
African American
Fasting Glucose
HDL Cholesterol
Triglycerides
Waist
Circumference**
Blood Pressure
Systolic**
Diastolic**
% Meeting MetS
criteria

Caucasian

83.66 mg/dL (12.72)
54.20 mg/dL (16.36)
76.74 mg/dL (40.24)
95.12 cm (20.80)

84.13 mg/dL (10.64)
57.56 mg/dL (15.86)
92.51 mg/dL (41.54)
82.28 cm (13.95)

124.94 mm Hg (13.85)
76.81 mm Hg (9.87)
22%

112.72 mm Hg (11.16)
67.85 mm Hg (6.46)
7.7%

Note. Values enclosed in parentheses indicate Standard Deviations. ** p < .001

Using Pillai’s trace, there was a significant effect of race on the overall model, V
= 0.36, F(6, 82) = 7.67, p < .001. Separate univariate ANOVAs on the outcome variables
revealed that, compared to Caucasians, African Americans had significantly greater waist
circumference, F(1, 87) = 10.98, p < .001 (Figure 1), diastolic blood pressure (mm Hg),
F(1, 87) = 24.07, p < .001, and systolic blood pressure (mm Hg), F(1, 87) = 20.16, p <
.001 (Figure 2). There were non-significant effects for HDL cholesterol levels, F(1, 87) =
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0.96, p = .331, triglycerides, F(1, 87) = 3.27, p = .074, and fasting glucose, F(1, 87) =
0.06, p = 0.81. As can be seen in Table 1, Caucasians exhibited higher means than
African Americans on these three variables.
Race disparities in health are multidimensional and can often reflect multiple
dimensions of social inequality. Socioeconomic status (SES) is one aspect of many that
combine to affect disparate numbers in disease prevalence in ethnic minorities (Farmer &
Ferraro, 2005; Franks, Muennig, Lubetkin, & Jia, 2006; Williams, Mohammed, Leavell,
& Collins, 2010). For this reason, a regression analysis was performed in order to assess
whether SES was a mediator of the relations between those metabolic risk factors
significantly related to race. SES was not related to waist circumference, β = .164, t(85)
= 1.20, p = .23, diastolic blood pressure, β = -.009, t(85) = -.142, p = .89, or systolic
blood pressure, β = .045, t(85) = .468, p = .64. As such, there were no potential
mediating effects of SES on the relation between race and these metabolic variables.
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Figure 1. Waist circumference means by race.
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Figure 2. Diastolic and systolic blood pressure means by race.
A chi-square test of independence was performed to examine the relation between
race and MetS. African American women were more likely to meet criteria for MetS
compared to Caucasian women, χ2(1) = 3.38, p = 0.033, with twenty-two percent of
African American women meeting criteria for MetS compared to 7.7% of Caucasian
women (Figure 3).
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Figure 3. Percentage likelihood of metabolic syndrome by race.

Hypothesis 2
The second hypothesis was to evaluate racial differences in PTSD diagnosis.
Based on diagnoses made from the CAPS, participants were divided into two groups:
those with PTSD and those without PTSD. A chi-square test of independence revealed a
significant association between race and the presence of PTSD, χ2(1) = 4.80, p = 0.014.
African American women were more likely to have PTSD than Caucasian women, 54%
and 31% respectively (Figure 4).
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Figure 4. Percentage likelihood of posttraumatic stress disorder by race.
Hypothesis 3
In order to examine whether PTSD is associated with larger values on metabolic
factors, a multivariate analysis of variance (MANOVA) was performed on six dependent
variables: fasting glucose, triglycerides, diastolic and systolic blood pressure, waist
circumference, and HDL cholesterol, with PTSD diagnosis as the independent variable.
Table 3.
Means and standard deviations for dependent variable by PTSD.
PTSD
Fasting Glucose
HDL Cholesterol*
Triglycerides
Waist
Circumference*
Blood Pressure
Systolic
Diastolic
% Meeting MetS
criteria

No PTSD

84.20 mg/dL (13.42)
51.54 mg/dL (13.15)
81.95.74 mg/dL (43.59)
94.42 cm (20.33)

83.60 mg/dL (9.93)
58.89 mg/dL (17.60)
84.98 mg/dL (30.89)
85.65 cm (17.38)

120.42 mm Hg (13.15)
74.78 mm Hg 10.14)
20%

118.93 mm Hg (14.84)
71.41 mm Hg (9.00)
12%

Note. Values enclosed in parentheses indicate Standard Deviations. * p <. 05
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Using Pillai’s trace, there was a significant effect of PTSD on the overall model,
V = 0.17, F(6, 82) = 2.78, p = .017. Separate univariate ANOVAs on the outcome
variables revealed significant effects on waist circumference, F(1, 87) = 4.81, p = .031
(Figure 5), such that women with PTSD had larger values than women without PTSD, as
well as significant effects on HDL cholesterol, F(1, 87) = 4.74, p = .032, such that
women with PTSD had significantly lower values than women without PTSD (Table 2).
There were no significant effects for diastolic blood pressure, F(1, 87) = 2.75, p = .101,
systolic blood pressure, F(1, 87) = 0.244, p = .623, triglycerides, F(1, 87) = .117, p =
.734, or fasting glucose, F(1, 87) = .023, p = .879.
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Figure 5. Waist circumference and HDL means by likelihood of PTSD
A chi-square test of independence was performed to examine the relation between
PTSD and MetS. There was no statistically significant association between PTSD and the
likelihood of MetS, χ2(1) = 1.198, p = 0.274. Women with PTSD were not more likely to
meet criteria for MetS, with the percentage of likelihood being 20% and 12%,
respectively.
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Hypothesis 4
A series of sequential regressions were performed to examine whether the
relationship between psychiatric symptoms and metabolic risk factors is different for
African American women and Caucasian women. Prior to analyses, race was coded as a
dichotomous variable (Caucasian = 0, African American = 1, the independent variable
(PTSD symptoms) was centered and product terms were created from these two variables
(Baron & Kenny, 1986). The following are the results from the regression analyses for
each of the metabolic risk factors.
Waist circumference. PTSD symptoms positively predicted waist circumference,
β = .309, t(85) = 2.14, p = .036, where greater PTSD symptoms were associated with
higher waist circumference. Race was also significantly related to waist circumference, β
= .289, t(85) = 2.88, p = .005, such that African Americans had higher values. However,
the association between PTSD symptoms and waist circumference was not moderated by
race, β = -.090, t(85) = -.631, p = .530 (see Figure 6).
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Figure 6. Waist circumference main effects of PTSD by race
Note. Low, medium, and high PTSD symptoms are represented by -1 SD, mean, and +1 SD, respectively
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Blood pressure. PTSD symptoms were not significantly related to systolic
blood pressure, β = .078, t(85) = .551, p = .583, or diastolic blood pressure, β = .096,
t(85) = .687, p = .494. Race was significantly related to systolic blood pressure, β =
.441, t(85) = 4.49, p < .001, and diastolic blood pressure, β = .467, t(85) = 4.82, p <
.001. Race did not moderate the effect between PTSD symptoms and systolic blood
pressure β = -.191, t(85) = -1.37, p = .175, or diastolic blood pressure, β = -.168, t(85)
= -1.22, p = .225.
Fasting glucose. Neither PTSD symptoms, β = .120, t(85) = .764, p = .447, nor
race, β = -.026, t(85) = -.235, p = .815, were significantly related to fasting glucose
levels. Race did not moderate between PTSD symptoms and fasting glucose, β = -.193,
t(85) = -1.24, p = .218.
HDL cholesterol. More PTSD symptoms were related to lower HDL cholesterol
levels, β = -.394, t(85) = -2.60, p = .011. Race was not significantly related to HDL
cholesterol levels, β = -.074, t(85) = -.706, p = .482. However, the association between
PTSD symptoms and HDL cholesterol was moderated by race, β = .372, t(85) = 2.48, p =
.015. Specifically, there is a negative relation between HDL levels and PTSD symptoms
for Caucasian women, while this was not the case for African American women.
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Figure 7. HDL interaction of posttraumatic stress disorder by race.
Triglycerides. Neither PTSD symptoms, β = -.091, t(85) = -.586 p = .560, nor
race, β = -.190, t(85) = -1.765, p = .081, were significantly related to triglyceride levels.
Also, race did not moderate the relationship between PTSD symptoms and triglyceride
levels, β = .146, t(85) = .949, p = .345.
Metabolic syndrome. A sequential logistic regression analysis was performed to
assess the likelihood of meeting criteria for MetS, based on PTSD symptoms and race. A
test of the full model against the constant only model was not significant, χ2(2) = 3.62, p
= 0.164, Nagelkerke R2 = .07, indicating that taken together, PTSD symptoms and race
did not reliably distinguish the likelihood of meeting criteria for MetS.
Further exploratory analyses. In addition to the hypothesis-driven analyses, the
possibility of hostility as a mediator of the relation between race and metabolic risk was
assessed. A direct logistic regression analysis was conducted with MetS entered as the
dependent variable and scores from the Cook Medley Hostility scale as the independent
predictor. The model was not statistically significant, χ2(1, N = 89) = .202, p = 0.653, as
hostility was not found to be a predictor of the likelihood of meeting criteria for MetS.
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In order to assess the possible effect of hostility on the relation between race and
metabolic risk factors a one-way analysis of variance was first conducted to examine if
there were differences in means. The ANOVA indicated that there was a significant
effect of race on hostility, F(1, 88) = 15.17, p < .001, such that African Americans (M =
13.74, SD = 5.92) had significantly higher hostility scores than Caucasians (M = 9.13, SD
= 5.05).
Earlier analysis revealed racial differences for waist circumference, diastolic and
systolic blood pressure. For this reason, a regression analysis was performed to assess
whether hostility mediated the relation between race and these metabolic risk factors.
While hostility was found to be a significant predictor of waist circumference, β = .229,
t(86) = 2.20 p = .031, hostility did not mediate the relation between race and waist
circumference, β = .118, t(86) = 1.08 p = .285. Regression analysis determined that
hostility was not related to diastolic blood pressure, β = .190, t(87) = 1.81 p = .074, or
systolic blood pressure, β = .109, t(87) = 1.02 p = .310.
Discussion
Previous research has shown that gender and race are critical aspects in metabolic
disease risk factors as well as PTSD symptomology. However, the effect of these
variables has received little empirical attention in assessing the possible relationship
between PTSD and MetS. The purpose of the current study was to investigate the effect
of race on the relation between PTSD diagnosis/symptomology and the presence of
metabolic risk factors/MetS diagnosis. This investigation found that race plays a
significant role in both the mental and physical health of women, and furthers the
understanding of the important relation between race, PTSD and metabolic disease risk.
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Hypothesis 1: Race and Metabolic Disease Risk
The first hypothesis examined the racial variability in metabolic risk factors and
the likelihood of meeting criteria for MetS. Results from this study were consist with
previous literature in finding that African American women had larger values for waist
circumference (Go et al., 2014; McDowell, Fryar, & Ogden, 2009), and diastolic and
systolic blood pressure, and were more likely to meet criteria for MetS than Caucasian
women (Go et al., 2014). Yet, contrary to what was hypothesized, there were no notable
differences found for fasting glucose, triglyceride, and HDL levels.
There is an overwhelming amount of literature indicating that African Americans
typically have higher fasting glucose levels and are at a significantly greater risk of
developing diabetes than Caucasians (Gregg, Gu, Cheng, Narayan, & Cowie, 2007; Gu,
Cowie, & Harris, 1998; Hu et al., 2001; McEwen et al., 2006; Saydah et al., 2004). The
age of the current sample (M = 29.9, SD = 5.67) may contribute to the non-significant
findings in fasting glucose levels.

According to the National Diabetes Fact sheet

statistics, diabetes is associated with older age with typical onset ≥ 45 y/o. Also, it is
estimated that there are only 3.7% individuals aged 20-44 with diagnosed and
undiagnosed diabetes, compared to 13.7% aged 45-64, and 26.9% older than 65. Given
that the current sample is both younger than 45 y/o and would fall within the smallest
percentage prevalence, this could explain, at least in part, why there were no detectable
differences in fasting glucose levels in the current sample. Future research could examine
the etiological pathways that cause racial disparities in diabetes, specifically if there are
additional mediating factors present that contribute to a greater disparity in African
Americans as they age.
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In looking deeper into the pattern of results for cholesterol lipids, the literature
suggest that, while African American women maintain an increased risk of mortality
from heart disease, they typically have a more favorable lipid profile than Caucasian
women (Ervin, 2009; Go et al., 2014; Koval, Setji, Reyes, & Brown, 2010; Kurella, Lo,
& Chertow, 2005). Findings from the current study add to the existing literature
documenting racial differences in this area. In screening participants for a clinical trial,
researchers from another study noticed a potential racial disparity in women who
responded to the advertisement (McIntosh et al., 2013). The researchers designed a
nested observational study in order to assess differences in metabolic risk factors in
African American women and Caucasian women. The researchers found only 7% of
African American women, compared to 41% of Caucasian women, had triglyceride
levels that met MetS criteria (McIntosh et al., 2013).
Another study sought to examine racial differences in lipid levels among a sample
of African American and Caucasian premenopausal (18-36 y/o) women (Lamon-Fava et
al., 2005). The authors found that compared to Caucasian women, African American
women had significantly higher BMI and waist-to-hip ratios, and significantly lower
triglyceride levels. Similarly, a study examining racial differences in physiological
patterns among women found that African American women had lower mean triglyceride
levels, higher blood pressure levels, and lower fasting glucose levels (Ladson et al.,
2011). Due to these racial differences in blood lipids, some researchers have suggested
that the current criteria for MetS may result in an underestimation of cardiovascular risk
in African Americans (Appel et al., 2006; McIntosh et al., 2013) and have led others to
suggest establishing different metabolic criteria depending on race (Appel et al., 2006;
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Haffner et al., 1999; Zeno et al., 2010).
Hypothesis 2: Race and PTSD
The second hypothesis examined racial variability in PTSD diagnosis. While the
gender disparity in PTSD is well documented in the literature, little is known about the
effect of race, and even less is known about the compounded effect of race and gender.
Consistent with previous literature (Himle, Baser, Taylor, Campbell, & Jackson, 2009,
Roberts, Gilman, Breslau, Breslau, & Koenen, 2011), the current study found that
African American women had higher rates of PTSD than Caucasian women.
Roberts et al. (2011) conducted a study examining the differences in exposure to
traumatic events and the development of posttraumatic stress disorder. The authors found
that the lifetime prevalence of PTSD was highest among African Americans (Roberts,
Gilman, Breslau, Breslau, & Koenen, 2011). Similarly, a study using data from the
National Epidemiologic Survey on Alcohol and Related Conditions found that the
lifetime prevalence of PTSD in African Americans (8.7%) was significantly higher than
both the general population (7.3%) and Caucasians (7.4%).
Another study examined race as a possible risk factor for PTSD in a group of
1,581 women (Seng, Kohn-Wood, McPherson, & Sperlich, 2011). The authors of this
study found that African American women had higher rates of lifetime PTSD (24%) and
fourfold higher rates of current PTSD (13.4%) when compared to non-African Americans
(Seng et al., 2011). Findings from the current study add to the existing literature by
further documenting a racial difference in women, as little attention has been given to this
population.
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Hypothesis 3: PTSD and Metabolic Disease Risk
The third hypothesis examined whether PTSD diagnosis was associated with
larger values on the metabolic risk factors and an increased likelihood of meeting criteria
for MetS. Women with PTSD had higher waist circumferences and lower HDL
cholesterol levels. While the relation between PTSD and waist circumference was
consistent with previous research and the findings from Dedert et al., 2010, the relation
between PTSD and HDL was a unique finding in this study in that this was not detected
in the previous Dedert et al. study. Yet the findings from the current study are consistent
with the literature indicating that PTSD was related to lower HDL levels (Kagan, Leskin,
Haas, Wilkins, & Foy, 1999; Karlovic, Buljan, Martinac, & Marcinko, 2004; Solter,
Thaller, Karlovic, & Crnkovic, 2002).
There were no significant differences in blood pressure, fasting glucose or
triglycerides levels. There was also no increased risk in the likelihood of meeting criteria
for MetS in women with PTSD. Though these findings may appear to be inconsistent
with research evidencing exaggerated cardiovascular risk in individuals with PTSD,
research focusing specifically on blood pressure and PTSD has been mixed, with some
demonstrating elevated basal blood pressure in participants with PTSD (Cohen et al.,
1997; Gerardi, Keane, Cahoon, & Klauminzer, 1994; Muraoka, Carlson, & Chemtob,
1998) and others finding no difference (McFall, Veith, & Murburg, 1992; Orr,
Meyerhoff, Edwards, & Pitman, 1998; Shalev, Bleich, & Ursano, 1990).
The findings in the current study may be due to the age of the sample. Because
hypertension, diabetes, and hypertriglyceridemia are age-related chronic illnesses, having
a relatively younger sample may account for the non-significant findings in the current
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sample. Women aged 20-34 account for only 6.8% of individuals with high blood
pressure, and less than 1% of those with hypertriglyceridemia. Also, studies showing a
significant relation between PTSD and cardiovascular risk typically use samples with
higher mean age than the one used in the current study. For example, the mean age in a
meta-analysis comparing adults with and without PTSD on psychophysiological variables
was 41.6 (Pole, 2007). This meta-analysis included 122 studies. Again, as the metabolic
risk factors assessed in the current study are age-related chronic conditions, participants
in the current study may have not yet developed significant medical problems in this area.
Another explanation for the inconsistent findings related to blood pressure may be
differences in the duration of PTSD symptoms. As numerous studies show that, relative
to individuals without PTSD, those with PTSD show exaggerated cardiovascular
responses to trauma cues, particularly heart rate variability (Cohen et al., 1997; Griffin,
2008; Vrana, Hughes, Dennis, Calhoun, & Beckham, 2009), this repeated autonomic
reactivity may result in structural and/or functional changes in the cardiovascular system
over time, ultimately leading to an increase in blood pressure (Buckley & Kaloupek,
2001). Again, this may explain why there are significant effects for PTSD and
cardiovascular risk factors in older individuals, and why these effects were not present in
the current study.
Hypothesis 4: PTSD symptoms, Race and Metabolic Disease Risk
The fourth hypothesis examined whether the relation between PTSD symptoms
and metabolic risk factors was different for African American women than for Caucasian
women. Contrary to what was expected, there were no differences found in the relation
between PTSD symptoms and blood pressure, fasting glucose, triglycerides or MetS.
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While PTSD symptoms and race were both positively related to waist circumference,
these variables were related to PTSD independent of each other. In other words, waist
circumference increased as PTSD symptomology increased in both African American
and Caucasian women.
However, women with PTSD also had significantly lower levels of HDL
cholesterol. While race was not independently related to HDL levels, Caucasian women
with PTSD had significantly lower HDL levels when compared to Caucasian women
without PTSD. This effect was not present in African American women. As mentioned
earlier, research has shown that African Americans typically have a more favorable lipid
profile than Caucasian women. As such, given that African Americans have a higher
prevalence and mortality for cardiovascular related diseases, these findings again beg the
question of whether lipid variables are reliable indicators of possible metabolic
abnormalities in African Americans and if race specific criteria should be used to assess
CVD risk.
Limitations
Within the current study, the term “African American” was used broadly to
represent individuals of African descent. As African Americans are not a monolithic
group and, as such, have varied cultural identities and social experiences, future studies
should consider the cultural implications of the African diaspora and it’s possible impact
on both physical and mental health outcomes.
Similarly, there is increasing literature that suggests a relation between perceived
discrimination in minority groups and both physical and mental health outcomes
(Bostwick, Boyd, Hughes, West, & McCabe, 2014; Haywood et al., 2014; Unger,
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Schwartz, Huh, Soto, & Baezconde-Garbanati, 2014). While the current study showed
significant racial differences in both physical and mental health variables, future studies
should consider the potential effects of perceived discrimination and minority related
stress specifically as it relates to disparities, both by gender and racial category.
Another limitation of the current study is the age of the sample. The metabolic
risk factors examined in this study are those that are present in chronic illnesses that
develop over time. For example, the median age of first acute myocardial infarction
(heart attack) is 65 years old in men and 56 years old in women. While the median age of
the current sample (M = 29.9) is significantly younger than the age of onset for most
cardiovascular diseases, differences by age in the current sample could have had an effect
on the results. The median age of individuals with PTSD (M = 32.4) was significantly
higher than that of those without PTSD (M = 28.0). Given that individuals with a
psychiatric diagnosis are more likely to use substances like tobacco and alcohol
(Beckham et al., 1997; Bremner, Southwick, Darnell, & Charney, 1996; Epstein,
Saunders, Kilpatrick, & Resnick, 1998; Lasser et al., 2000), and are also more likely to
have more sedentary lifestyles (Goodwin, 2003; Ramsay & Farmer, 1988), the difference
in years and the deleterious effects of PTSD on decisions related to physical health could
have had an effect on the differences found in metabolic health by PTSD diagnosis.
Future research should include variables that measure the frequency of substance use and
physical activity.
Conclusion
African American women are at the intersection of heightened prevalence across
categories of race and gender. As identified in the literature, African American women
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bear a disproportionate physical burden from metabolic-related conditions and are at
higher risk of psychiatric morbidity. Findings from the current study are not only
consistent with research suggesting disparate rates of PTSD and MetS in African
American women, but also suggest that these disparities are evident in younger
populations.
There has been little empirical attention given to the possible effects of race on
the relation between psychiatric and physical health. The current study sought to shed
light on the possible effect of race on the relation between PTSD and metabolic health.
The significant findings between race and the metabolic components of MetS warrant
further research to help elucidate the mechanisms involved in development of the MetS
and the trajectories leading to cardiovascular disease. Future studies should include
longitudinal data. Time-trend analysis would allow for observations of psychiatric and
metabolic data and their relation over time. As metabolic risk factors develop into chronic
conditions over time, each measure would have its own psychophysiological
underpinning that may be informative about possible racial differences in the
pathophysiology of PTSD.
Finally, future research on the influence of race on the relation between
psychiatric symptomology and metabolic health would benefit from the consideration of
cultural variables that may potentially provide direction in the etiology of disease
pathways. Diagnosis can be challenging as manifestations of mental disorders vary with
gender, race, and culture. Further research is needed to develop appropriate treatments
and prevention efforts to reduce the burden of metabolic disease risk, particularly in highrisk populations.
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Appendix A

Correlation Matrix of Study Variables

Appendix B
Summary of Index Traumas

Trauma Category
Combat
Physical/Sexual Assault
Child
Adult
Accident/MVA/Fire
Domestic Violence
Death of Someone
Witness/Experience
Violence
Child
Adult
Natural Disaster
Other

Frequency (%)
8.6
19.8
18.5
6.2
7.4
17.3
4.9
11.1
1.2
4.9
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